Technical Analysis for CYP - Cynata Therapeutics Ltd
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| A | 0.270 | 10.20% | 0.025 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing High | Bullish | 0.00% | |
| Expansion Breakout | Bullish Swing Setup | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| New 52 Week High | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% |
| Alert | Time |
|---|---|
| Possible Pocket Pivot | about 11 hours ago |
| 2x Volume Pace | about 11 hours ago |
| Up 10% | about 12 hours ago |
| Up 2 ATRs | about 12 hours ago |
| 1.5x Volume Pace | about 12 hours ago |
Get a Trading Assistant
Cynata Therapeutics Ltd Description
Cynata Therapeutics Limited is a stem cell and regenerative medicine company. The Company is engaged in the development and commercialization of a mesenchymal stem cell (MSC) technology for human therapeutic use, Cymerus. Its Cymerus technology facilitates manufacture of MSCs from a single donor and a single donation. The Company's Cymerus platform stem cell technology is based upon stem cells known as mesenchymoangioblasts (MCAs). The Company's technology utilizes induced pluripotent stem cells (iPSCs) originating from an adult donor as the starting material for generating MCAs and in turn for manufacturing the MSC therapeutic product. The Cymerus platform provides a source of MSCs that is independent of donor limitations and provides an off-the-shelf stem cell platform for therapeutic product use. The Company's MSCs produced using Cymerus technology, can be used to treat unrelated patients, without any need to match the recipient to the donor.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Manufacturing Medicine Biotechnology Life Sciences Biology Therapeutic Product Regenerative Medicine Regenerative Stem Cell Stem Cells Cell Biology Induced Stem Cells Mesenchymal Stem Cell The Star
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.285 |
| 52 Week Low | 0.105 |
| Average Volume | 143,662 |
| 200-Day Moving Average | 0.154 |
| 50-Day Moving Average | 0.201 |
| 20-Day Moving Average | 0.225 |
| 10-Day Moving Average | 0.240 |
| Average True Range | 0.014 |
| RSI (14) | 75.73 |
| ADX | 16.99 |
| +DI | 41.584 |
| -DI | 18.301 |
| Chandelier Exit (Long, 3 ATRs) | 0.244 |
| Chandelier Exit (Short, 3 ATRs) | 0.226 |
| Upper Bollinger Bands | 0.259 |
| Lower Bollinger Band | 0.191 |
| Percent B (%b) | 1.16 |
| BandWidth | 30.133 |
| MACD Line | 0.015 |
| MACD Signal Line | 0.012 |
| MACD Histogram | 0.0026 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.308 | ||||
| Resistance 3 (R3) | 0.308 | 0.297 | 0.301 | ||
| Resistance 2 (R2) | 0.297 | 0.287 | 0.296 | 0.299 | |
| Resistance 1 (R1) | 0.283 | 0.281 | 0.290 | 0.283 | 0.297 |
| Pivot Point | 0.272 | 0.272 | 0.275 | 0.271 | 0.272 |
| Support 1 (S1) | 0.258 | 0.262 | 0.265 | 0.258 | 0.243 |
| Support 2 (S2) | 0.247 | 0.256 | 0.246 | 0.241 | |
| Support 3 (S3) | 0.233 | 0.247 | 0.239 | ||
| Support 4 (S4) | 0.233 |
